Novo Nordisk uses AI to fast-track drug launches, expand India role

Novo Nordisk is aiming to slash the time it takes to bring new drugs to market by up to two-thirds using AI, ​a top executive said, as the Danish drugmaker looks to regain momentum in ‌the booming obesity drugs market.